Summary
Overview
Work History
Education
Skills
Timeline
Generic
Ronald L. Cosmas

Ronald L. Cosmas

Brandon,FL

Summary

A visionary who excels at leading transformation, spearheading business development, directing profitable growth, and building successful sales organizations. Instrumental in the disruption of a 20+ year duopoly as a member of the Sientra Management team and the transformation of a novel device (Keller Funnel) to becoming the "standard of care" within the aesthetic surgery arena. C-Suite business and personnel development leader, offering strategic cross-functional success. Proficient at championing strategic initiatives to drive new product adoption and sales growth. Adept at championing marketing programs, leading profitable product development initiatives and implementing successful sales and marketing programs. Experienced executive with strong track record in leadership and governance. Adept at driving strategic initiatives and fostering collaborative environments. Known for flexibility in addressing evolving needs and achieving measurable results. Skilled in financial oversight, risk management, and stakeholder engagement. Recognized for integrity, decisiveness, and effective communication.

Overview

2025
2025
years of professional experience

Work History

Board of Director

02.2024 - Current
  • Brave is a network of surgeons, volunteers and industry leaders challenging the system by guiding all breast cancer survivors through the complex world of breast reconstructive options and fearlessly advocating for access to their choice of care

Chief Commercial Officer

GC Aesthetics
12.2018 - 06.2024
  • Company Overview: Member of the Executive Management team of GC Aesthetics, the 3rd largest aesthetic and reconstructive breast implant manufacture in the world
  • Within the last 24 months, I have successfully launched 2 innovative new breast implants and the first breast implant to be MDR certified within the European Union
  • With manufacturing facilities in both Scotland and France, responsibilities include the Global Sales & Distribution efforts across multiple platforms
  • Strategically leading the global commercial organization in more than 70 partner countries and 10 direct countries around the world to maximizing revenue, while implementing cost containment mechanisms and reducing 'Cost of Goods'
  • 2024 Revenue Projection of $70.9M
  • 20% average Year over Year Growth with 15 Consecutive Quarters of Double-Digit Growth
  • 6 Unique product launches within the past 36 months
  • 4 Consecutive Years of +20% Top Line Revenue Growth
  • 1st Breast Implant to receive EU Medical Device Regulation (MDR) within the European Union
  • Commercial and Regulatory oversite for 10 direct sales organizations
  • Negotiate Topline global distribution with over 70 partners to leverage local access to providers
  • Member of the Executive Management team of GC Aesthetics, the 3rd largest aesthetic and reconstructive breast implant manufacture in the world

United States Project Director

GC Aesthetics
  • Member of the GC Aesthetics leadership team
  • Primary responsibility to secure an Investigational Device Exemption (IDE) Study in the United States, leading the corporate initiative of attaining PMA approval for the GC Aesthetics product portfolio
  • Submission of Pre-Q protocol which led to the Face-to-Face meeting with the FDA on December 12, 2019
  • Successful negotiation of 10-year ($50,000,000) Master Service Agreement with Clinical Research Organization (ICON)

Director of Sales

OBP Medical
10.2017 - 12.2018
  • Primary member of the OBP Medical leadership team
  • Responsible for the creation, development, cultivation, and training of a national independent sales organization
  • Increased total number of independent representatives from 2 to 37
  • Grow domestic sales by 100%

Vice President of Sales

Keller Medical, Inc.
09.2014 - 10.2017
  • Company Overview: Integral part of the Keller Medical Executive leadership team which negotiated the acquisition of Keller Medical by Allergan Corporation
  • Responsibilities include the management of 50 independent sales consultants, while developing marketing strategies and future market development
  • Annual sales growth combined with cost containment was a primary component for the company's acquisition by Allergan for greater than 10 times domestic sales
  • Management of 50 independent sales consultants nationally
  • 2015-2017: Increase Domestic Sales Revenue by 21% Year over Year
  • Spearheaded a new product development effort
  • Integral part of the Keller Medical Executive leadership team which negotiated the acquisition of Keller Medical by Allergan Corporation

Sientra Strategic Advisor

Sientra, Inc.
08.2007 - 08.2014
  • Company Overview: Santa Barbara, CA directly to the founder and CEO, Mr
  • Hani Zeini
  • Responsibilities included the strategic development and advancement of the Sientra portfolio
  • Current Product Line development and improvement
  • New technology acquisition
  • Santa Barbara, CA directly to the founder and CEO, Mr
  • Hani Zeini

Southeast Director of Sales

Sientra, Inc.
  • As an original member of the Sientra Management team, I worked tirelessly in the F.D.A
  • Approval process, development of the disruptive marketing and sales strategy and the facilitation of the IPO
  • Upon F.D.A
  • Approval, key areas of responsibilities include, but were not confined to the management of 10 Plastic Surgery Consultants, marketing the disruptive 5th generation of Silimed Breast Implants and Tissue Expanders
  • 2007-2014 achieved +20% revenue growth YOY
  • 2012 Launch Sientra Silicone Gel Breast Implants in the U.S
  • 2007 Orchestrated the successful domestic launch of the Sientra Tissue Expander portfolio
  • Over 5,000 hours of operating room experience

Sales Representative

Allergan Medical
06.1999 - 07.2007
  • Company Overview: formally Inamed Corp and McGhan Medical
  • Responsibilities include but were not confined to the sales and marketing of saline and silicone breast implants within a defined geographic region
  • Additional responsibilities include the education and training of new representatives, surgeons, and residents within the Southeastern region
  • Budget achievement 1999-2007
  • Presidents Club 2000-2006
  • 2003 & 2005 The Excellence Award
  • 2001 Inaugural Crystal Eagle Award for Personal Commitment and Leadership
  • Over 5,000 hours of Operating Room experience
  • Formally Inamed Corp and McGhan Medical

Southern Region Account Executive

LySonix, Inc.
02.1996 - 06.1999
  • Company Overview: (an Inamed Company)
  • This innovative technology was the first of its kind in the plastic surgery arena
  • Responsibilities included the creation and development of groundbreaking market strategies and the sales and training of the LySonix 2000 Ultrasonic Lipoplasty System
  • Budget achievement 1997-1999
  • Over 1,500 hours of operating room experience
  • (an Inamed Company)

Education

Bachelor of Science - Criminology, Political Science

Florida State University
Tallahassee, FL
06.

Skills

  • Project scope
  • Agreement negotiation
  • Innovation and creativity
  • Business intelligence tracking
  • Project management
  • Relationship building
  • Idea development and brainstorming
  • Stakeholder relations
  • Customer relationship management
  • Creative thinking
  • Multitasking
  • Multitasking Abilities

Timeline

Board of Director

02.2024 - Current

Chief Commercial Officer

GC Aesthetics
12.2018 - 06.2024

Director of Sales

OBP Medical
10.2017 - 12.2018

Vice President of Sales

Keller Medical, Inc.
09.2014 - 10.2017

Sientra Strategic Advisor

Sientra, Inc.
08.2007 - 08.2014

Sales Representative

Allergan Medical
06.1999 - 07.2007

Southern Region Account Executive

LySonix, Inc.
02.1996 - 06.1999

United States Project Director

GC Aesthetics

Southeast Director of Sales

Sientra, Inc.

Bachelor of Science - Criminology, Political Science

Florida State University

Similar Profiles

CREATE PROFILE
Ronald L. Cosmas